Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-23T16:22:18.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk Factors of Stroke in Pakistan: A Dedicated Stroke Clinic Experience

Published online by Cambridge University Press:  02 December 2014

Fawad Taj ,
Rehan Zahid ,
Umm-e-Rubab Syeda ,
Muhammed Murtaza ,
Shahzad Ahmed  and
Ayeesha Kamran Kamal
Fawad Taj
Affiliation:
Section of Neurology, Department of Medicine, Stroke Service
Rehan Zahid
Affiliation:
Medical College, Aga Khan University Hospital
Umm-e-Rubab Syeda
Affiliation:
Medical College, Aga Khan University Hospital
Muhammed Murtaza
Affiliation:
Medical College, Aga Khan University Hospital
Shahzad Ahmed
Affiliation:
Sindh Medical College, Dow University of Health Sciences, Karachi, Pakistan
Ayeesha Kamran Kamal*
Affiliation:
Section of Neurology, Department of Medicine, Stroke Service
*
Section of Neurology, Department of Medicine, Aga Khan University, Stadium Road, PO Box 3500, Karachi, 74300, Pakistan.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Secondary prevention of cerebrovascular disease through dedicated stroke clinics has been shown to decrease recurrent vascular events in patients. However, there is limited literature describing such stroke clinic experiences from low and middle income countries. This study describes patient characteristics and observations made at the first systematized stroke clinic in Pakistan.

Methods:

Aretrospective audit of medical records of all patients presenting between September 2006 and August 2008 with a cerebrovascular event was conducted. Information about clinical presentation, modifiable risk factors and laboratory and radiological investigations was collected. Burden of disability was assessed using Modified Rankin score. Data was entered and analyzed using SPSS 14.0.

Results:

159 patients with a mean age of 57.0 ± 13.9 years were included in this study and 34.6% of all patients were women. 108 patients were diagnosed with ischemic stroke (67.9%) while 34 patients presented with hemorrhagic stroke (21.4%) and 17 patients presented with transient ischemic attacks (10.7%). Hypertension was the most common modifiable risk factor seen in 78.0%, followed by diabetes in 40.3% and dyslipidemia in 31.5%. At presentation to clinic, only 26.0% patients with dyslipidemia and 64.5% patients with hypertension were on appropriate medications.

Conclusion:

A high prevalence of modifiable risk factors such as hypertension in stroke patients was observed and it presents an opportunity for conventional interventions in Pakistan. Systematized clinics for stroke and an algorithmic approach in primary care towards stroke may improve the implementation of evidence based secondary prevention strategies in developing countries.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 2 , March 2010 , pp. 252 - 257
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Feigin, VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. [Reflection and Reaction]. 2007 Feb;6(2):94–7.Google Scholar
2. Omran, AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971 Oct;49(4):509–38.CrossRefGoogle ScholarPubMed
3. Feigin, VL, Lawes, CM, Bennett, DA, Barker-Collo, SL, Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009 Apr;8(4):355–69.CrossRefGoogle ScholarPubMed
4. Truelsen, T, Heuschmann, P, Bonita, R, Arjundas, G, Dalal, P, Damasceno, A, et al. Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol. 2007 Feb;6 (2):134–9.Google Scholar
5. Moussouttas, M, Aguilar, L, Fuentes, K, Anyanwu, B, Manassarians, H, Papamitsakis, N, et al. Cerebrovascular disease among patients from the Indian subcontinent. Neurology. 2006 Sep 12; 67(5):894–6.Google Scholar
6. Feigin, VL LC, Bennett, DA, Anderson, CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. [Review]. 2003 Jan;2(1):43–53.CrossRefGoogle ScholarPubMed
7. Lin, Y, Li, YS, Xu, Q, Shi, GW, Li, HW, Geng, JL. [The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke]. Zhonghua Nei Ke Za Zhi. 2007 Sep;46(9):736–9.Google ScholarPubMed
8. Mouradian, MS, Hussain, MS, Lari, H, Salam, A, Senthilselvan, A, Dean, N, et al. The impact of a stroke prevention clinic in diagnosing modifiable risk factors for stroke. Can J Neurol Sci. 2005 Nov;32(4):496–500.CrossRefGoogle ScholarPubMed
9. Bonita, R, Beaglehole, R. Recovery of motor function after stroke. Stroke. 1988 Dec;19(12):1497–500.Google Scholar
10. Brott, T, Adams, HP Jr., Olinger, CP, Marler, JR, Barsan, WG, Biller, J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864–70.Google Scholar
11. Rankin, J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 May;2(5):200–15.CrossRefGoogle ScholarPubMed
12. Wade, DT, Collin, C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud. 1988;10(2):64–7.CrossRefGoogle ScholarPubMed
13. Adams, HP Jr., Bendixen, BH, Kappelle, LJ, Biller, J, Love, BB, Gordon, DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan; 24(1):35–41.CrossRefGoogle Scholar
14. Diagnosis and classification of diabetes mellitus. American Diabetes Association. Diabetes Care. 2006 Jan;29 Suppl 1: S43–8.Google Scholar
15. Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA, Izzo, JL Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21; 289(19):2560–72.CrossRefGoogle ScholarPubMed
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486–97.Google Scholar
17. Brown, MM, Rudd, A, McGovern, R. Transient ischemic attack-proposed new definition. N Engl J Med. 2003 Apr 17;348(16): 1607–9; author reply -9.Google Scholar
18. Petrea, RE, Beiser, AS, Seshadri, S, Kelly-Hayes, M, Kase, CS, Wolf, PA. Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study. Stroke. 2009 Apr;40 (4)1032–7.Google Scholar
19. Appelros, P, Stegmayr, B, Terent, A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009 Apr;40(4): 1082–90.Google Scholar
20. Jacobs, DR Jr., McGovern, PG, Blackburn, H. The US decline in stroke mortality: what does ecological analysis tell us? Am J Public Health. 1992 Dec;82(12):1596–9.Google Scholar
21. Lin, T, Chen, CH, Chou, P. Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary health care. J Hum Hypertens. 2004 Feb;18(2):97–105.Google Scholar
22. Amarenco, P, Labreuche, J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009 May;8(5):453–63.CrossRefGoogle ScholarPubMed